1. Perez-Ibave, DC. Burciaga-Flores, CH. Elizondo-Riojas, MA. Prostate-specific antigen (PSA) as a possible biomarker in non-prostatic cancer: A review. Cancer Epidemiology. 2018; 54: 48 – 55
2. Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, Agoritsas T, Dahm P. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018 Sep 5;362:k3519. doi: 10.1136/bmj.k3519. PMID: 30185521; PMCID: PMC6283370
3. Gunadi MI. Nilai Ambang Batas Prostate – Specific Antigen (PSA) dan Prostate - Specific Antigen (PSA) Density pada Penderita dengan Kecurigaan Karsinoma Prostat. Makassar: Program Studi Ilmu Bedah Fakultas Kedokteran Universitas Hasanuddin. 2020.
4. Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018 May 8;319(18):1914-1931. doi: 10.1001/jama.2018.3712. PMID: 29801018.
5. US Preventive Services Task Force; Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, Doubeni CA, Ebell M, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Siu AL, Tseng CW. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710. Erratum in: JAMA. 2018 Jun 19;319(23):2443. PMID: 29801017.
6. Alpert PF. New Evidence for the Benefit of Prostate-specific Antigen Screening: Data From 400,887 Kaiser Permanente Patients. Urology. 2018 Aug;118:119-126. doi: 10.1016/j.urology.2018.02.049. Epub 2018 May 14. PMID: 29772218.
7. National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management. 2021. https://www.nice.org.uk/guidance/ng131/chapter/recommendations.
8. Parker C, Castro E, Fizazi K, Heidenreich A, Ost P, Procopio G, Tombal B, Gillessen S; ESMO Guidelines Committee. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Sep;31(9):1119-1134. doi: 10.1016/j.annonc.2020.06.011. Epub 2020 Jun 25. PMID: 32593798.
9. Wei JT, et al. Early Detection of Prostate Cancer: AUA/SUO guideline (2023). American Urological Association. 2023. https://www.auanet.org/guidelines-and-quality/guidelines/early-detection-of-prostate-cancer-guidelines.
10. Merriel SWD, Pocock L, Gilbert E, Creavin S, Walter FM, Spencer A, Hamilton W. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 2022 Feb 7;20(1):54. doi: 10.1186/s12916-021-02230-y. PMID: 35125113; PMCID: PMC8819971.